Glenmark Pharma Ltd.

BSE: 532296 | NSE: GLENMARK |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category

Series: EQ | ISIN: INE935A01035 | SECTOR: Pharmaceuticals & DrugsPharmaceuticals & Drugs

Success

Alert

Please select a Day.

Info

Open trading A/c Open trading A/c

Glenmark Pharm Glenmark Pharma Ltd. | BSE 2015.25 -4.30 (-0.21%) | NSE 2010.60 -9.50 (-0.47%) | Trade | Add

BSE Live

Dec 26, 16:01

2015.25 -4.30 (-0.21%)

Volume

AVERAGE VOLUME

5-Day

25,939

10-Day

18,470

30-Day

25,126

3,510

Prev. Close

2019.55
Open Price

2043.80

Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)

NSE Live

Dec 26, 15:55

2010.60 -9.50 (-0.47%)

Volume

AVERAGE VOLUME

5-Day

715,244

10-Day

540,164

30-Day

1,029,643

206,579

Prev. Close

2020.10
Open Price

2018.00

Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)

Financials

Print/Copy to Excel : Go

Balance Sheet of Glenmark Pharma (in Rs. Cr.)	Mar 15	Mar 14	Mar 13	Mar 12	Mar 11
	12 mths	12 mths	12 mths	12 mths	12 mths
EQUITIES AND LIABILITIES
SHAREHOLDER'S FUNDS
Equity Share Capital	27.13	27.12	27.09	27.05	27.03
Total Share Capital	27.13	27.12	27.09	27.05	27.03
Reserves and Surplus	4,924.92	2,878.90	2,496.09	2,158.66	1,952.71
Total Reserves and Surplus	4,924.92	2,878.90	2,496.09	2,158.66	1,952.71
Total Shareholders Funds	4,952.05	2,906.02	2,523.18	2,185.71	1,979.74
NON-CURRENT LIABILITIES
Long Term Borrowings	0.00	0.00	0.00	254.35	274.57
Deferred Tax Liabilities [Net]	132.40	36.42	28.58	23.80	22.93
Other Long Term Liabilities	121.92	51.88	84.95	77.84	3.12
Long Term Provisions	0.00	0.00	0.00	0.00	0.00
Total Non-Current Liabilities	254.32	88.30	113.53	355.99	300.62
CURRENT LIABILITIES
Short Term Borrowings	347.60	353.32	308.85	222.09	797.38
Trade Payables	1,566.79	562.68	426.20	270.50	175.86
Other Current Liabilities	378.70	223.63	442.71	64.41	100.80
Short Term Provisions	151.38	95.64	71.08	70.36	19.80
Total Current Liabilities	2,444.47	1,235.27	1,248.83	627.36	1,093.84
Total Capital And Liabilities	7,650.84	4,229.59	3,885.54	3,169.06	3,374.21
ASSETS
NON-CURRENT ASSETS
Tangible Assets	1,152.48	439.17	267.12	216.27	216.02
Intangible Assets	78.19	9.35	8.54	7.49	7.76
Capital Work-In-Progress	286.48	79.78	168.90	65.57	31.25
Other Assets	0.00	0.00	0.00	0.00	0.00
Fixed Assets	1,524.87	531.82	448.08	292.70	257.37
Non-Current Investments	1,659.52	1,409.24	1,294.33	1,083.27	1,041.25
Deferred Tax Assets [Net]	0.00	0.00	0.00	0.00	0.00
Long Term Loans And Advances	854.63	670.52	922.80	955.20	1,540.15
Other Non-Current Assets	13.86	8.39	180.92	101.83	53.06
Total Non-Current Assets	4,052.88	2,619.98	2,846.13	2,433.00	2,891.83
CURRENT ASSETS
Current Investments	0.00	0.00	0.00	0.00	0.00
Inventories	736.63	210.43	190.15	175.93	157.01
Trade Receivables	2,440.83	1,136.04	485.10	358.74	189.34
Cash And Cash Equivalents	48.55	108.46	167.79	47.51	30.95
Short Term Loans And Advances	356.32	151.43	66.94	67.05	23.69
OtherCurrentAssets	15.62	3.26	129.44	86.83	81.39
Total Current Assets	3,597.96	1,609.61	1,039.41	736.06	482.38
Total Assets	7,650.84	4,229.59	3,885.54	3,169.06	3,374.21
OTHER ADDITIONAL INFORMATION
CONTINGENT LIABILITIES, COMMITMENTS
Contingent Liabilities	5,878.77	3,364.16	2,530.05	1,819.93	762.73
CIF VALUE OF IMPORTS
Raw Materials	396.93	40.06	29.01	24.47	15.88
Stores, Spares And Loose Tools	0.00	0.00	0.00	0.00	0.00
Trade/Other Goods	0.00	0.00	0.00	0.00	0.00
Capital Goods	71.10	17.84	56.78	10.26	16.69
EXPENDITURE IN FOREIGN EXCHANGE
Expenditure In Foreign Currency	617.59	306.15	327.65	201.65	155.89
REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS
Dividend Remittance In Foreign Currency	0.02	0.04	0.04	0.01	0.01
EARNINGS IN FOREIGN EXCHANGE
FOB Value Of Goods	2,972.05	703.87	670.86	540.58	302.00
Other Earnings	157.87	148.97	29.82	25.60	31.93
BONUS DETAILS
Bonus Equity Share Capital	15.84	15.84	15.84	15.84	15.84
NON-CURRENT INVESTMENTS
Non-Current Investments Quoted Market Value	0.19	0.21	0.28	0.25	0.45
Non-Current Investments Unquoted Book Value	1,659.47	1,409.20	1,294.29	1,083.23	1,041.20
CURRENT INVESTMENTS
Current Investments Quoted Market Value	--	--	--	--	--
Current Investments Unquoted Book Value	--	--	--	--	--